Ranitidine 150mg Film-coated Tablets - Patient Information Leaflet (PIL) by Accord Healthcare Limited Relonchem Ranitidine 75mg Tablets (12): PL 20395/0079 3. Through our internal manufacturing facilities and partner organisations worldwide, we provide a wide variety of products. Accord Healthcare are recalling all unexpired stock of the below products from pharmacies and retail stores as a precautionary measure.Accord Healthcare are recalling all unexpired stock of the Ranitidine 150mg Film-Coated Tablets and Ranitidine 300mg Film-Coated Tablets products from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.Stop supplying the above products immediately and remove from the shelves within your store. We are an integrated generics pharmaceutical company with a wide range of services and products from manufacturing to development to sales and marketing. Latest recall information: OTC Concepts Ltd, Relconchem Ltd, Noumed Life Sciences and Medreich PLC recall 21 November. An investigation into other potentially impacted products is continuing and further updates will be provided as the investigation progresses.For stock control enquiries please contact Customer Service team on +44 (0) 1484 665733 or For medical information enquiries please contact Pharmacovigilance Department on OTC Concepts Ltd, Relonchem Ltd, Noumed Life Sciences Ltd and Medreich Plc. Covers a range of non-medicinal products suitable for use at home.An essential guide on pharmacovigilance of medicinal products for human use. Contact details. Medley Pharma has recalled unexpired stocks of ranitidine over possible contamination with N-nitrosodimethylamine (NDMA).The Medicines and Healthcare products Regulatory Agency issued a drug alert, on 16 December 2019, recalling ranitidine 150mg and 300mg tablets from pharmacies and wholesalers as a precautionary measure.Ranitidine medicines, which belong to a class of medicines known as histamine-2 blockers, are used to reduce the production of stomach acid in patients with conditions such as heartburn and stomach ulcers.Medley Pharma is the 13th manufacturer to recall unexpired batches of ranitidine, with 33 such products recalled so far over possible contamination with NDMA – a probable human carcinogen.The recalls continued in November 2019, with Creo Pharma and Tillomed Laboratories recalling one ranitidine product each. Perrigo recall 25 October 2019. +44 (0) 1525 292344 or For stock control enquiries please contact Relonchem Customer Service team on +44 (0) 151 422 1200 or For medical information enquiries please contact Relonchem Pharmacovigilance Department on Having less acid in your stomach allows ulcers and inflammation to heal. Numark Ranitidine 75mg Film Cote… We are an integrated generics pharmaceutical company with a wide range of services and products from manufacturing to development to sales and marketing. Ranitidine is a type of medicine called a histamine antagonist, also known as an H2 blocker. Please contact info@noumed.co.uk if you wish to learn more about the products Noumed can offer. Noumed Indigestion Relief.

Ranitidine Tablets 150mg, Ranitidine Capsules 150mg, Ranitidine Capsules 300mg and Ranitidine Syrup 15mg/mL were distributed nationwide to Aurobindo Pharma USA, Inc. and AuroHealth wholesale and distributor customers 28 September 2018 through 19 September 2019. Creo Pharma, Tillomed Laboratories, Omega Pharma Limited, Galpharm International, Rosemont Pharmaceuticals, OTC Concepts Ltd, Relconchem Ltd and Noumed Life Sciences Ltd have also recalled their ranitidine products. Ranitidine 150mg Tablets not available PL 20416/0321 CRESCENT PHARMA LIMITED UK Ranitidine 300 mg film-coated tablets not available PL 21880/0024 MEDREICH PLC UK Ranitidine 300mg Tablets not available PL 20416/0322 CRESCENT PHARMA LIMITED UK Ranitidine 300mg Tablets not available PL 44041/0030 NOUMED LIFE SCIENCES UK Ranitidine 300mg